The BMJ Press Notice: Monday 10 February 2025 Correction to research paper: Efficacy of psilocybin for treating symptoms of depression A correction has been made to a research paper published by The BMJ on 1 May 2024: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. Overall, ...
Company acknowledges “misjudgment” following a BMJ investigation, but medics call for a global ban on industry-funded medical education Medical education provider Medscape has bowed to pressure and agreed to permanently remove a series of accredited medical education courses on smoking cessation funded by the tobacco industry giant Philip Morris International ...
Industry tied programmes provide information to schoolchildren as young as 9 Initiatives normalise drinking and downplay the long term health risks of alcohol, argue experts Public health experts are calling for a ban on alcohol industry funded education programmes in UK universities and schools, which they say normalise drinking and ...
Risks highest soon after starting drugs, underscoring need for increased caution in early stages of treatment, say experts Antipsychotic use in people with dementia is associated with elevated risks of a wide range of serious adverse outcomes including stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney ...
And the lifetime risk of irregular heart rhythm increased from one in four to one in three over the last 20 years, findings show The lifetime risk of atrial fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) has increased from one in four to ...
Latest BMJ Commission reports call for political and societal commitment to stem the worsening trajectory of health in the UK We must act on the social determinants of health (the conditions in which people are born, grow, live, work, and age) and place sustainability at the core of the NHS’s ...
Low dose esketamine should be considered for individuals with depressive symptoms in pregnancy, say researchers A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds a clinical trial published by The BMJ today. The results ...
Investigation sheds new light on process designed to keep patients safe during industrial action BMA says it takes concerns around patient safety “incredibly seriously” An investigation published by The BMJ today reveals new details of requests to recall striking junior doctors from picket lines for patient safety reasons. Documents show ...
First study to assess risk associated with widely used progestogens Prolonged use of certain progestogen hormone drugs is associated with an increased risk of developing a type of brain tumour known as an intracranial meningioma, finds a study from France published by The BMJ today. The researchers say this study ...
The future of the NHS depends on having the right staff who feel valued and proud to work in the health service Looking after the NHS workforce is not only an ethical imperative but also a sound investment and must be a top priority, say experts in the third report ...
Copyright © 2025 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
